Platinum-Montaur Life Sciences, LLC v. Navidea Biopharmaceuticals, Inc.

943 F.3d 613
CourtCourt of Appeals for the Second Circuit
DecidedNovember 25, 2019
Docket18-3535-cv
StatusPublished
Cited by213 cases

This text of 943 F.3d 613 (Platinum-Montaur Life Sciences, LLC v. Navidea Biopharmaceuticals, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Second Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Platinum-Montaur Life Sciences, LLC v. Navidea Biopharmaceuticals, Inc., 943 F.3d 613 (2d Cir. 2019).

Opinion

18-3535-cv Platinum-Montaur Life Sciences, LLC v. Navidea Biopharmaceuticals, Inc.

2 United States Court of Appeals 3 for the Second Circuit 4 5 August Term, 2019 6 7 (Argued: September 5, 2019 Decided: November 25, 2019) 8 9 Docket No. 18-3535-cv 10 11 _____________________________________ 12 13 PLATINUM-MONTAUR LIFE SCIENCES, LLC, 14 15 Plaintiff-Appellant, 16 17 v. 18 19 NAVIDEA BIOPHARMACEUTICALS, INC., 20 21 Defendant-Third-Party-Plaintiff-Appellee, 22 23 v. 24 25 PLATINUM PARTNERS CREDIT OPPORTUNITIES MASTER FUND, LP, 26 27 Third-Party-Defendant. 28 29 _____________________________________ 30 Before: 31 32 KATZMANN, Chief Judge, WALKER AND PARK, Circuit Judges. 33 34 Plaintiff Platinum-Montaur Life Sciences, LLC (“Platinum-Montaur”), 35 appeals a decision of the United States District Court for the Southern District of 36 New York (Caproni, J.) granting the motion to dismiss of defendant Navidea 1 Biopharmaceuticals, Inc., on grounds that Platinum-Montaur lacked Article III 2 standing. Because the district court did not first determine whether there was 3 complete diversity of citizenship between the parties, it is unclear whether it had 4 subject-matter jurisdiction under 28 U.S.C. § 1332. We thus VACATE and 5 REMAND for further proceedings consistent with this opinion. 6 7 ROBERT J. BURNS (Warren E. Gluck, Barbara 8 P. Parlin, and Kathryn B. Daly on the brief), 9 Holland & Knight LLP, New York, New 10 York for Plaintiff-Appellant. 11 12 ROBERT C. FOLLAND, Barnes & Thornburg, 13 LLP, Columbus, Ohio for Defendant- 14 Appellee. 15 16 Park, Circuit Judge:

17 Platinum-Montaur Life Sciences, LLC (“Platinum-Montaur”) sued

18 Navidea Biopharmaceuticals, Inc. (“Navidea”) in state court over a contract

19 dispute. Navidea removed the case to the United States District Court for the

20 Southern District of New York (Caproni, J.). Navidea asserted that the district

21 court had diversity jurisdiction under 28 U.S.C. § 1332 but it did not identify

22 Platinum-Montaur’s citizenship. The parties conducted limited informal

23 jurisdictional discovery but failed to determine Platinum-Montaur’s citizenship.

24 Instead of ordering further jurisdictional discovery, the district court assumed

25 that it had subject-matter jurisdiction, stating that it could proceed because it had

26 no “good faith basis to believe that there is not complete diversity.”

2 1 We hold that the district court erred by failing to determine whether it had

2 diversity jurisdiction before deciding Navidea’s motion to dismiss. Accordingly,

3 we VACATE and REMAND for further proceedings consistent with this

4 opinion.

5 BACKGROUND

6 In 2017, Platinum-Montaur sued Navidea in New York state court to

7 collect on a debt. Navidea then filed a notice of removal in the United States

8 District Court for the Southern District of New York. Navidea claimed that the

9 federal court had “diversity jurisdiction under 28 U.S.C. § 1332(a).”

10 Section 1332(a) gives federal courts jurisdiction to hear controversies

11 “between . . . citizens of different States.” Navidea stated that it was “a Delaware

12 corporation, with a principal place of business in Ohio,” making it a citizen of

13 Delaware and Ohio. 28 U.S.C. § 1332(c)(1) (“[A] corporation shall be deemed to

14 be a citizen of every State . . . by which it has been incorporated and of the

15 State . . . where it has its principal place of business.”).

16 But Navidea’s notice of removal did not fully specify Platinum-Montaur’s

17 citizenship. Platinum-Montaur is a limited liability company (“LLC”), which

18 takes the citizenship of all of its members. See Bayerische Landesbank, New York

3 1 Branch v. Aladdin Capital Mgmt. LLC, 692 F.3d 42, 49 (2d Cir. 2012). Navidea

2 stated that Platinum-Montaur was an LLC with three members—two individual

3 residents of New Jersey and Platinum Partners Value Arbitrage Fund, L.P.

4 (“PPVA”), a Cayman Islands Limited Partnership (“LP”). For the purposes of

5 diversity jurisdiction, a partnership takes the citizenship of all of its partners. See

6 Carden v. Arkoma Assocs., 494 U.S. 185, 195–96 (1990). Therefore, Platinum-

7 Montaur is a citizen of every state of which PPVA’s partners are citizens.

8 Navidea did not identify these partners in its notice of removal, leaving

9 Platinum-Montaur’s citizenship uncertain.

10 Because it was unclear whether the parties before it were diverse, the

11 district court ordered “informal jurisdictional discovery in order to determine the

12 citizenship of [PPVA].” After looking into its own citizenship, Platinum-

13 Montaur determined that one of PPVA’s partners was Platinum Partners Value

14 Arbitrage Funds (USA) L.P. (“PPVA Onshore”), a “feeder fund intended for U.S.

15 investors” with around 220 limited partners and which took the citizenship of

16 each partner. Carden, 494 U.S. at 195–96. Platinum-Montaur stated that it had

17 tried but failed to determine whether any of PPVA Onshore’s partners was a

4 1 citizen of either Delaware or Ohio, which would destroy diversity of citizenship

2 between Platinum-Montaur and Navidea. 1

3 At a status conference, Platinum-Montaur told the court that it was

4 “seeing . . . hundreds of feeder funds, multiple LLCs, [and] unincorporated

5 entities,” in its ownership structure. After contacting some of PPVA Onshore’s

6 partners in an effort to identify their citizenship, Platinum-Montaur decided to

7 stop and wait on the district court’s direction because it was “unclear” to them

8 “when you are just one cog in the chain of the uphill ownership structure how

9 that affects diversity jurisdiction.”

10 The district court asked Platinum-Montaur whether it planned to move for

11 a remand to state court, and Platinum-Montaur responded that it was “really

12 trying to follow the Court’s directives” on this issue. The court decided to

13 conclude its jurisdictional inquiry and stated, “I’m not inclined to order [further

14 jurisdictional discovery]. At this point I don’t have a good faith basis to believe

15 that there is not complete diversity.”

1 PPVA’s two other partners were an offshore feeder fund and a Delaware LLC that served as PPVA’s general partner. Platinum-Montaur would have to identify the citizenship of these two entities as well as PPVA Onshore to determine its own citizenship.

5 1 Having assumed subject-matter jurisdiction, the district court later granted

2 Navidea’s motion to dismiss, finding that as a matter of contract law, Platinum-

3 Montaur had assigned away all of its rights to Navidea’s debts and therefore

4 lacked standing to sue. Platinum-Montaur appealed that ruling, and both parties

5 briefed the issue of standing but not subject-matter jurisdiction.

6 STANDARD OF REVIEW

7 This court may “sua sponte delve into the issue of whether there is a factual

8 basis to support” subject-matter jurisdiction. Velez v.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
943 F.3d 613, Counsel Stack Legal Research, https://law.counselstack.com/opinion/platinum-montaur-life-sciences-llc-v-navidea-biopharmaceuticals-inc-ca2-2019.